Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical Efficacy of POP Surgery
NCT02599311Phase 3Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Aug 2015
- Primary completion
- Oct 2019
- Countries
- 1
01
Overview
Phase 3, open-label trial (4 arms), sponsored by Peking University People's Hospital. Primary endpoint: The objective recurrent rate at 1 year. Status: unknown.
Beyond the preview
Go deeper on NCT02599311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02599311.